Skip to content

China Kidney Patient Trials Network

China Kidney Patient Trials Network

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05036850
Acronym
CKPTN
Enrollment
1200
Registered
2021-09-08
Start date
2021-09-27
Completion date
2031-02-28
Last updated
2023-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Kidney Diseases

Keywords

Chronic Kidney Disease, Diabetic Nephropathy, Hypertensive Kidney Disease, Glomerulonephritis, GN, Focal Segmental Glomerulosclerosis, FSGS, Membranous Nephropathy, Minimal Change Disease, IgA Nephropathy, Glomerulonephritis not otherwise specified

Brief summary

This is a prospective multi-centre, observational cohort study of incident and prevalent patients diagnosed with a kidney disease in China.

Interventions

None listed

Sponsors

George (Beijing) Clinical Research Co. Ltd.
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
2 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Documented diagnosis of primary kidney disease 2. Regular visits (at least 6 monthly) with a physician at a participating site 3. eGFR \> 15 ml/min/1.73 m2 4. ≥ 2 years of age 5. Willing and able to sign informed consent 6. Willing to be approached about participation in interventional research studies

Exclusion criteria

* 1\. Life-expectancy of less than 6 months

Design outcomes

Primary

MeasureTime frameDescription
eGFR (estimated Glomerular Filtration Rate)Collected six monthly, up to 5 yearsRoutine results
AlbuminuriaCollected six monthly, up to 5 yearsRoutine results

Countries

China

Contacts

Primary ContactFanHan Hsu
CKPTN@georgeclinical.com+61 2 8052 4300
Backup ContactDan Yuan
CKPTN@georgeclinical.com+86 201082800476

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026